UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Trim28 contributes to EMT via regulation of E-cadherin and N-cadherin in lung cancer cell lines

PloS one, 2014-07, Vol.9 (7), p.e101040-e101040

2014

Volltextzugriff (PDF)

cAMP/CREB-regulated LINC00473 marks LKB1-inactivated lung cancer and mediates tumor growth

The Journal of clinical investigation, 2016-06, Vol.126 (6), p.2267-2279

2016

Volltextzugriff (PDF)

TGF-β—inducible microRNA-183 silences tumor-associated natural killer cells

Proceedings of the National Academy of Sciences - PNAS, 2014-03, Vol.111 (11), p.4203-4208

2014

Volltextzugriff (PDF)

E2F inhibition synergizes with paclitaxel in lung cancer cell lines

PloS one, 2014-05, Vol.9 (5), p.e96357

2014

Volltextzugriff (PDF)

Interactions between E2F1 and SirT1 regulate apoptotic response to DNA damage

Nature cell biology, 2006-09, Vol.8 (9), p.1025-1031

2006

Volltextzugriff (PDF)

Prognostic and Predictive Value of a Malignancy-Risk Gene Signature in Early-Stage Non-Small Cell Lung Cancer

JNCI : Journal of the National Cancer Institute, 2011-12, Vol.103 (24), p.1859-1870

2011

Volltextzugriff (PDF)

CDK4/6 inhibition synergizes with inhibition of P21-Activated Kinases (PAKs) in lung cancer cell lines

PloS one, 2021-06, Vol.16 (6), p.e0252927-e0252927

2021

Volltextzugriff (PDF)

Histone deacetylase inhibitors downregulate checkpoint kinase 1 expression to induce cell death in non-small cell lung cancer cells

PloS one, 2010-12, Vol.5 (12), p.e14335-e14335

2010

Volltextzugriff (PDF)

MEK Inhibition Modulates Cytokine Response to Mediate Therapeutic Efficacy in Lung Cancer

Cancer research (Chicago, Ill.), 2019-11, Vol.79 (22), p.5812-5825

2019

Volltextzugriff (PDF)

Role of Stat3 in Regulating p53 Expression and Function

Molecular and Cellular Biology, 2005-09, Vol.25 (17), p.7432-7440

2005

Volltextzugriff (PDF)

Evaluating somatic tumor mutation detection without matched normal samples

Human genomics, 2017-09, Vol.11 (1), p.22-22, Article 22

2017

Volltextzugriff (PDF)

Somatic Mutations and Ancestry Markers in Hispanic Lung Cancer Patients

Journal of thoracic oncology, 2017-12, Vol.12 (12), p.1851-1856

2017

Volltextzugriff (PDF)

Expression and alternative splicing of the cyclin-dependent kinase inhibitor-3 gene in human cancer

The international journal of biochemistry & cell biology, 2017-10, Vol.91 (Pt B), p.98-101

2017

Volltextzugriff (PDF)

A Sensitive NanoString-Based Assay to Score STK11 (LKB1) Pathway Disruption in Lung Adenocarcinoma

Journal of thoracic oncology, 2016-06, Vol.11 (6), p.838-849

2016

Volltextzugriff (PDF)

PAXIP1 Potentiates the Combination of WEE1 Inhibitor AZD1775 and Platinum Agents in Lung Cancer

Molecular cancer therapeutics, 2016-07, Vol.15 (7), p.1669-1681

2016

Volltextzugriff (PDF)

E2F1: A new role in the DNA damage response

Cell cycle (Georgetown, Tex.), 2011-06, Vol.10 (11), p.1718-1718

Cress, W. Douglas

2011

Volltextzugriff (PDF)

Impact of upfront cellular enrichment by laser capture microdissection on protein and phosphoprotein drug target signaling activation measurements in human lung cancer: Implications for personalized medicine

Proteomics. Clinical applications, 2015-10, Vol.9 (9-10), p.928-937

2015

Volltextzugriff (PDF)

A small-molecule E2F inhibitor blocks growth in a melanoma culture model

Cancer research (Chicago, Ill.), 2008-08, Vol.68 (15), p.6292-6299

2008

Volltextzugriff (PDF)

CX3CR1 deficiency-induced TIL tumor restriction as a novel addition for CAR-T design in solid malignancies

iScience, 2023-04, Vol.26 (4), p.106443-106443, Article 106443

2023

Volltextzugriff (PDF)

Regulation of E2F1 Function by the Nuclear Corepressor KAP1

The Journal of biological chemistry, 2007-10, Vol.282 (41), p.29902-29909

2007

Volltextzugriff (PDF)

Grading of lung adenocarcinomas with simultaneous segmentation by artificial intelligence (GLASS-AI)

NPJ precision oncology, 2023-07, Vol.7 (1), p.68-68, Article 68

2023

Volltextzugriff (PDF)

Loss of cellular identity in common pre-clinical models of serine‑threonine kinase 11 (Liver kinase B1) loss

Cancer treatment and research communications, 2021, Vol.26, p.100286-100286, Article 100286

2021

Volltextzugriff (PDF)

The Retinoblastoma Tumor Suppressor Transcriptionally Represses Pak1 in Osteoblasts

PloS one, 2015-11, Vol.10 (11), p.e0142406-e0142406

2015

Volltextzugriff (PDF)

A stitch in time and CDK9

Cell cycle (Georgetown, Tex.), 2017-05, Vol.16 (9), p.823-824

Cress, W. Douglas

2017

Volltextzugriff (PDF)

RhoBTB2 (DBC2) Is a Mitotic E2F1 Target Gene with a Novel Role in Apoptosis

The Journal of biological chemistry, 2008-01, Vol.283 (4), p.2353-2362

2008

Volltextzugriff (PDF)

1 – 25 von 122

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(119)
Mit Volltextzugriff
(118)

Publikationsform

Artikel
(121)
Reviews
(1)

Sprache

Englisch
(122)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Trim28 contributes to EMT via regulation of E-cadherin and N-cadherin in lung cancer cell lines

cAMP/CREB-regulated LINC00473 marks LKB1-inactivated lung cancer and mediates tumor growth

TGF-β—inducible microRNA-183 silences tumor-associated natural killer cells

E2F inhibition synergizes with paclitaxel in lung cancer cell lines

Interactions between E2F1 and SirT1 regulate apoptotic response to DNA damage

Prognostic and Predictive Value of a Malignancy-Risk Gene Signature in Early-Stage Non-Small Cell Lung Cancer

CDK4/6 inhibition synergizes with inhibition of P21-Activated Kinases (PAKs) in lung cancer cell lines

Histone deacetylase inhibitors downregulate checkpoint kinase 1 expression to induce cell death in non-small cell lung cancer cells

MEK Inhibition Modulates Cytokine Response to Mediate Therapeutic Efficacy in Lung Cancer

Role of Stat3 in Regulating p53 Expression and Function

Evaluating somatic tumor mutation detection without matched normal samples

Somatic Mutations and Ancestry Markers in Hispanic Lung Cancer Patients

Expression and alternative splicing of the cyclin-dependent kinase inhibitor-3 gene in human cancer

A Sensitive NanoString-Based Assay to Score STK11 (LKB1) Pathway Disruption in Lung Adenocarcinoma

PAXIP1 Potentiates the Combination of WEE1 Inhibitor AZD1775 and Platinum Agents in Lung Cancer

E2F1: A new role in the DNA damage response

Impact of upfront cellular enrichment by laser capture microdissection on protein and phosphoprotein drug target signaling activation measurements in human lung cancer: Implications for personalized medicine

A small-molecule E2F inhibitor blocks growth in a melanoma culture model

CX3CR1 deficiency-induced TIL tumor restriction as a novel addition for CAR-T design in solid malignancies

Regulation of E2F1 Function by the Nuclear Corepressor KAP1

Grading of lung adenocarcinomas with simultaneous segmentation by artificial intelligence (GLASS-AI)

Loss of cellular identity in common pre-clinical models of serine‑threonine kinase 11 (Liver kinase B1) loss

The Retinoblastoma Tumor Suppressor Transcriptionally Represses Pak1 in Osteoblasts

A stitch in time and CDK9

RhoBTB2 (DBC2) Is a Mitotic E2F1 Target Gene with a Novel Role in Apoptosis

Suchergebnisse filtern